Skip to main content

Fco. Javier Muñoz Gall

Institutions of which they are part

Main researcher
Pneumology
Vall Hebron Institut de Recerca

Fco. Javier Muñoz Gall

Institutions of which they are part

Main researcher
Pneumology
Vall Hebron Institut de Recerca

Projects

Exposición a partículas diesel y su impacto en diferentes fenotipos asmáticos: Mecanismos inmunológicos e inflamatorios.

IP: Fco. Javier Muñoz Gall
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 99220
Reference: PI18/00344
Duration: 01/01/2019 - 30/06/2023

Fibrosis pulmonar y pneumonitis por hipersensibilidad por exposición a aves: efecto de la exposición antigénica mínima persistente.

IP: Fco. Javier Muñoz Gall
Collaborators: -
Funding agency: Fundació Catalana de Pneumologia
Funding: 12000
Reference: FUCAP/PROJECTES/2017/MUÑOZ
Duration: 01/01/2017 - 31/12/2019

Grup de Recerca de Pneumologia

IP: Jaume Ferrer Sancho
Collaborators: Esther Rodríguez González, Sergi Martí Beltran, Mª Jose Jurado Luque, Marc Miravitlles Fernández, Ana Villar Gomez, Antonio Román Broto, Antonio Álvarez Fernandez, Victor Monforte Torres, Patricia Lloberes Canadell, Javier de Gracia Roldán, Odile Romero Santo-Tomas, Sonia Lopez Rodriguez, Montserrat Murillo Andres, Miriam Barrecheguren Fernández, Carles Bravo Masgoret, Mario Culebras Amigo, Fco. Javier Muñoz Gall, Marta Castro D la Visitación, Gabriel Sampol Rubio, Maria Antonia Ramon Belmonte, Rosa Lloria Verges, Mercedes Pallero Castillo, Mª Jesús Cruz Carmona, Cristina Berastegui Garcia, Manuel López Meseguer, Susana Gómez Olles, Berta Saez Gimenez, Iñigo Ojanguren Arranz, Eva Polverino
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 20000
Reference: 2017SGR0434
Duration: 01/01/2017 - 30/09/2021

Estudio de los mecanismos implicados en la génesis y evolución del asma (Proyecto MEGA): Creación y seguimiento a largo plazo de una cohorte de pacientes asmáticos

IP: Fco. Javier Muñoz Gall
Collaborators: Iñigo Ojanguren Arranz
Funding agency: Instituto de Salud Carlos III
Funding: 140965
Reference: PI15/01900
Duration: 01/01/2016 - 30/11/2020

Related news

Vall d'Hebron participated in the study in which more than half of the patients who received treatment with bacteriophages experienced significant improvements

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Pulmonary hypertension is a risk factor for patients who need surgery and, therefore, defining strategies for its management is important to allow a favorable clinical evolution.

Related professionals

Maria Jose Abadias Medrano

Maria Jose Abadias Medrano

Predoctoral researcher
Read more
Tayná  Marques

Tayná Marques

Infectious Diseases
Read more
Neus Prades Gimeno

Neus Prades Gimeno

Research assistant
Systemic Diseases
Read more
René Yeltsin Carvajal Junco

René Yeltsin Carvajal Junco

Predoctoral researcher
Clinical Neuroimmunology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.